[
  {
    "id": "aemt-dex-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which blood glucose value indicates the need for IV dextrose?",
    "choices": [
      "110 mg/dL",
      "85 mg/dL",
      "58 mg/dL",
      "140 mg/dL"
    ],
    "correctAnswer": "58 mg/dL",
    "rationale": "Hypoglycemia requires rapid glucose correction.",
    "clinicalPearl": "Always confirm hypoglycemia when possible."
  },
  {
    "id": "aemt-dex-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Why is D10 often preferred over D50 in pediatric patients?",
    "choices": [
      "Longer shelf life",
      "Lower risk of extravasation injury",
      "Faster onset",
      "Less need for IV access"
    ],
    "correctAnswer": "Lower risk of extravasation injury",
    "rationale": "Lower concentration reduces tissue damage risk.",
    "clinicalPearl": "Hypertonic solutions can cause severe tissue necrosis."
  },
  {
    "id": "aemt-dex-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which assessment is most important after dextrose administration?",
    "choices": [
      "Heart rate",
      "Blood glucose reassessment",
      "Blood pressure",
      "Skin temperature"
    ],
    "correctAnswer": "Blood glucose reassessment",
    "rationale": "Treatment effectiveness must be confirmed.",
    "clinicalPearl": "Treat, reassess, and prevent recurrence."
  },

  {
    "id": "aemt-nalox-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone administration primarily improves which patient condition?",
    "choices": [
      "Hypotension",
      "Respiratory depression",
      "Chest pain",
      "Hypoglycemia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone reverses opioid-induced respiratory depression.",
    "clinicalPearl": "Airway and ventilation always come first."
  },
  {
    "id": "aemt-nalox-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Which response is most likely after naloxone administration?",
    "choices": [
      "Gradual sedation",
      "Improved respirations with agitation",
      "Immediate pain relief",
      "Decreased heart rate"
    ],
    "correctAnswer": "Improved respirations with agitation",
    "rationale": "Rapid opioid reversal may cause acute withdrawal.",
    "clinicalPearl": "Expect agitation—protect yourself and the patient."
  },
  {
    "id": "aemt-nalox-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Why must patients receiving naloxone be closely monitored?",
    "choices": [
      "Naloxone causes hypoglycemia",
      "Naloxone has a shorter duration than many opioids",
      "Naloxone causes bradycardia",
      "Naloxone permanently blocks opioid receptors"
    ],
    "correctAnswer": "Naloxone has a shorter duration than many opioids",
    "rationale": "Re-narcotization can occur after naloxone wears off.",
    "clinicalPearl": "Repeat dosing may be required."
  },
  {
    "id": "aemt-dex-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which blood glucose value indicates the need for IV dextrose?",
    "choices": [
      "110 mg/dL",
      "85 mg/dL",
      "58 mg/dL",
      "140 mg/dL"
    ],
    "correctAnswer": "58 mg/dL",
    "rationale": "Hypoglycemia requires rapid glucose correction.",
    "clinicalPearl": "Always confirm hypoglycemia when possible."
  },
  {
    "id": "aemt-dex-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Why is D10 often preferred over D50 in pediatric patients?",
    "choices": [
      "Longer shelf life",
      "Lower risk of extravasation injury",
      "Faster onset",
      "Less need for IV access"
    ],
    "correctAnswer": "Lower risk of extravasation injury",
    "rationale": "Lower concentration reduces tissue damage risk.",
    "clinicalPearl": "Hypertonic solutions can cause severe tissue necrosis."
  },
  {
    "id": "aemt-dex-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which assessment is most important after dextrose administration?",
    "choices": [
      "Heart rate",
      "Blood glucose reassessment",
      "Blood pressure",
      "Skin temperature"
    ],
    "correctAnswer": "Blood glucose reassessment",
    "rationale": "Treatment effectiveness must be confirmed.",
    "clinicalPearl": "Treat, reassess, and prevent recurrence."
  },
  {
    "id": "aemt-nalox-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone administration primarily improves which patient condition?",
    "choices": [
      "Hypotension",
      "Respiratory depression",
      "Chest pain",
      "Hypoglycemia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone reverses opioid-induced respiratory depression.",
    "clinicalPearl": "Airway and ventilation always come first."
  },
  {
    "id": "aemt-nalox-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Which response is most likely after naloxone administration?",
    "choices": [
      "Gradual sedation",
      "Improved respirations with agitation",
      "Immediate pain relief",
      "Decreased heart rate"
    ],
    "correctAnswer": "Improved respirations with agitation",
    "rationale": "Rapid opioid reversal may cause acute withdrawal.",
    "clinicalPearl": "Expect agitation—protect yourself and the patient."
  },
  {
    "id": "aemt-nalox-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Why must patients receiving naloxone be closely monitored?",
    "choices": [
      "Naloxone causes hypoglycemia",
      "Naloxone has a shorter duration than many opioids",
      "Naloxone causes bradycardia",
      "Naloxone permanently blocks opioid receptors"
    ],
    "correctAnswer": "Naloxone has a shorter duration than many opioids",
    "rationale": "Re-narcotization can occur after naloxone wears off.",
    "clinicalPearl": "Repeat dosing may be required."
  }
]

